Журнал «Современная Наука»

Russian (CIS)English (United Kingdom)
 MOSCOW +7(495)-142-86-81

Escalation and de-escalation of dual antiplatelet therapy in patients with acute coronary syndrome

Shamraev R. L.  (post-graduate student, Volgograd regional clinical cardiology centre)

Ilukhin O. V.  (candidate of medical Sciences, assistant, Volgograd State Medical University)

Lopatin Y. M.  (doctor of medical Sciences, Professor, Volgograd State Medical University; head of the I cardiology Department, Volgograd regional clinical cardiology centre)

Dual anti-platelet therapy (DAAT) using aspirin and a P2Y12 inhibitor of the platelet receptor is included in the standard of care for patients with acute coronary syndrome. It is known that stronger drugs - ticagrelor and prasugrel significantly reduce ischemic events compared with clopidogrel, while their use is associated with an increased risk of bleeding. Therefore, in clinical practice, there is often a switch from one drug to another, but there are no official documents and recommendations on this issue. In this review, we have covered the major major works on the issue of escalation / de-escalation of DAAT lately.

Keywords:DAAT escalation, DAAT de-escalation, clopidogrel, ticagrelor, prasugrel
 

Read the full article …

Citation link:
Shamraev R. L., Ilukhin O. V., Lopatin Y. M. Escalation and de-escalation of dual antiplatelet therapy in patients with acute coronary syndrome // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2018. -№12. -С. 194-198
LEGAL INFORMATION:
Reproduction of materials is permitted only for non-commercial purposes with reference to the original publication. Protected by the laws of the Russian Federation. Any violations of the law are prosecuted.
© ООО "Научные технологии"

Terms Publications

Issues of the journals (Archive)

ECONOMICS AND LAW
HUMANITIES
NATURAL AND TECHNICAL SCIENCES
COGNITION

Серия - Natural and Technical Sciences